Free Trial

Vaxxinity (VAXX) Competitors

Vaxxinity logo
$0.0001 0.00 (0.00%)
As of 07/23/2025 12:53 PM Eastern

VAXX vs. SCPS, NAVB, EVLO, CMRA, GNCAQ, GNCA, ARDS, STAB, AMPE, and EFTR

Should you be buying Vaxxinity stock or one of its competitors? The main competitors of Vaxxinity include Scopus BioPharma (SCPS), Navidea Biopharmaceuticals (NAVB), Evelo Biosciences (EVLO), Comera Life Sciences (CMRA), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), Ampio Pharmaceuticals (AMPE), and eFFECTOR Therapeutics (EFTR). These companies are all part of the "pharmaceutical products" industry.

Vaxxinity vs. Its Competitors

Scopus BioPharma (NASDAQ:SCPS) and Vaxxinity (NASDAQ:VAXX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment and analyst recommendations.

In the previous week, Scopus BioPharma's average media sentiment score of 0.00 equaled Vaxxinity'saverage media sentiment score.

Company Overall Sentiment
Scopus BioPharma Neutral
Vaxxinity Neutral

82.9% of Vaxxinity shares are held by institutional investors. 5.1% of Scopus BioPharma shares are held by insiders. Comparatively, 64.1% of Vaxxinity shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Scopus BioPharmaN/A N/A N/A
Vaxxinity N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scopus BioPharmaN/AN/A-$11.61MN/AN/A
VaxxinityN/AN/A-$56.93M-$0.450.00

Scopus BioPharma has a beta of -0.19, meaning that its share price is 119% less volatile than the S&P 500. Comparatively, Vaxxinity has a beta of -23.96, meaning that its share price is 2,496% less volatile than the S&P 500.

Summary

Scopus BioPharma and Vaxxinity tied by winning 2 of the 4 factors compared between the two stocks.

Get Vaxxinity News Delivered to You Automatically

Sign up to receive the latest news and ratings for VAXX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VAXX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VAXX vs. The Competition

MetricVaxxinityPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$13K$783.82M$5.57B$9.42B
Dividend YieldN/A4.84%4.05%3.99%
P/E Ratio0.001.4028.1520.08
Price / SalesN/A25.01401.6884.07
Price / CashN/A19.5636.1958.45
Price / Book0.006.928.625.83
Net Income-$56.93M-$4.13M$3.24B$258.27M
7 Day PerformanceN/A2.37%3.55%2.69%
1 Month PerformanceN/A5.11%11.01%12.91%
1 Year PerformanceN/A8.30%35.56%21.81%

Vaxxinity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VAXX
Vaxxinity
N/A$0.00
flat
N/A-99.9%$13KN/A0.0090High Trading Volume
SCPS
Scopus BioPharma
N/A$0.00
flat
N/AN/A$13KN/A0.009
NAVB
Navidea Biopharmaceuticals
N/A$0.00
flat
N/A-50.0%$10K$8.13K0.0010
EVLO
Evelo Biosciences
N/A$0.00
flat
N/AN/A$9KN/A0.00120News Coverage
Options Volume
CMRA
Comera Life Sciences
N/A$0.00
flat
N/AN/A$6K$1.00M0.002
GNCAQ
Genocea Biosciences
N/AN/AN/AN/A$6KN/A0.0070
GNCA
Genocea Biosciences
N/AN/AN/AN/A$6K$1.91M0.0070
ARDS
Aridis Pharmaceuticals
N/A$0.00
+∞
N/AN/A$5KN/A0.0030Gap Up
STAB
Statera Biopharma
N/A$0.00
flat
N/A-83.3%$5KN/A0.0020Negative News
High Trading Volume
AMPE
Ampio Pharmaceuticals
N/A$0.00
-73.0%
N/AN/A$3KN/A0.0020Gap Down
EFTR
eFFECTOR Therapeutics
0.0832 of 5 stars
$0.00
flat
N/A-99.6%$1KN/A0.0010Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:VAXX) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners